Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-22-033655

← back to feed
Filed
Nov 25, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Nov 17, 2022 362.27M sh
Capex Q1 2021 · Mar 31, 2021 $41.51K
Capex Q1 2021 · Mar 31, 2020 $7.18K
Operating Cash Flow Q1 2021 · Mar 31, 2021 $17.96K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$40.44K
Cash And Equivalents Q1 2021 · Mar 31, 2021 $292.54K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $398.97K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $175.31K
Stockholders Equity Q1 2021 · Mar 31, 2021 $1.95M
Stockholders Equity Q1 2021 · Dec 31, 2020 $1.98M
Stockholders Equity restated Q1 2021 · Mar 31, 2020 $1.66M
Stockholders Equity Q1 2021 · Dec 31, 2019 $1.74M
Current Liabilities Q1 2021 · Mar 31, 2021 $839.9K
Current Liabilities Q1 2021 · Dec 31, 2020 $1.09M
Total Liabilities Q1 2021 · Mar 31, 2021 $1.5M
Total Liabilities Q1 2021 · Dec 31, 2020 $1.79M
Current Assets Q1 2021 · Mar 31, 2021 $1.15M
Current Assets Q1 2021 · Dec 31, 2020 $1.4M
Total Assets Q1 2021 · Mar 31, 2021 $3.45M
Total Assets Q1 2021 · Dec 31, 2020 $3.77M
Total Assets Q1 2021 · Mar 31, 2020 $3.03M
Eps Basic Q1 2021 · Mar 31, 2021 $0.00
Eps Basic Q1 2021 · Mar 31, 2020 $0.00
Sga Expense Q1 2021 · Mar 31, 2021 $244.48K
Sga Expense Q1 2021 · Mar 31, 2020 $274.99K
Net Income Q1 2021 · Mar 31, 2021 $91.65K
Net Income Q1 2021 · Mar 31, 2020 $8.22K
Gross Profit Q1 2021 · Mar 31, 2021 $337.13K
Gross Profit Q1 2021 · Mar 31, 2020 $292.36K
Cost Of Revenue Q1 2021 · Mar 31, 2021 $350.39K
Cost Of Revenue Q1 2021 · Mar 31, 2020 $361.62K
Revenue Q1 2021 · Mar 31, 2021 $687.51K
Revenue Q1 2021 · Mar 31, 2020 $653.98K